Considering angiogenesis as a hallmark of metastasis and tumor development and CD31 as a marker for angiogenesis, which widely expressed on the endothelial cells [30, 33, 34], further evidence for the anti-metastatic effect of compound B was provided by a significant impediment to the expression in lung tissues of CD31. This evidence concerns the gene PECAM1 and neoplasm.